APA (7th ed.) Citation

AA, E., HY, T., D, G., SJ, C., F, A., S, W., . . . JC, T. (2021). A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma. The Journal of investigative dermatology, 141(9), 2238. https://doi.org/10.1016/j.jid.2020.12.038

Chicago Style (17th ed.) Citation

AA, Emran, Tseng HY, Gunatilake D, Cook SJ, Ahmed F, Wang S, Hersey P, Gallagher SJ, and Tiffen JC. "A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma." The Journal of Investigative Dermatology 141, no. 9 (2021): 2238. https://doi.org/10.1016/j.jid.2020.12.038.

MLA (9th ed.) Citation

AA, Emran, et al. "A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma." The Journal of Investigative Dermatology, vol. 141, no. 9, 2021, p. 2238, https://doi.org/10.1016/j.jid.2020.12.038.